Ontology highlight
ABSTRACT: Objective
It is unclear why despite a comparable cardiometabolic risk profile, "metabolically benign" overweight/obese individuals show an elevated risk of cardiovascular disease compared to normal weight individuals.Design and methods
In cross-sectional analyses, we compared levels of ectopic fat (epicardial, pericardial, and hepatic fat) and adipokines (leptin, soluble leptin receptor, and high molecular weight [HMW] adiponectin) among metabolically benign (MBO) and at-risk overweight/obese (ARO), and metabolically benign normal weight (MBNW) women, screened for the Kronos Early Estrogen Prevention Study. We defined "metabolically benign" with ≤ 1, and "at-risk" with ≥2 components of the metabolic syndrome.Results
Compared to MBO women, ARO women had significantly
SUBMITTER: Ogorodnikova AD
PROVIDER: S-EPMC3748250 | biostudies-literature | 2013 Aug
REPOSITORIES: biostudies-literature